National
J&J COVID-19 vaccine candidate protects monkeys after single dose – FierceBiotech
Scientists led by Beth Israel Deaconess Medical Center in Boston tested seven different COVID-19 vaccine candidates from J&J in nonhuman primates, landing on one that prevented the virus from infecting the animals’ lungs with a single dose. The company plans …
Rather than building its COVID-19 vaccine candidate with mRNAthe new technology that rivals Moderna and Pfizer have turned toJohnson & Johnson selected an older vaccine platform that had proven to be safe in diseases like RSV and Ebola. Now, its reporting that a single dose of the vaccine protected nonhuman primates in a preclinical study.
Scientists led by Beth Israel Deaconess Medical Center in Boston tested seven different vaccine candidates from J&J’s Janssen unit in 32 monkeys. Ano…
